Abstract

Journal of HematotherapyVol. 6, No. 2 Re: Toward a Worldwide Standard for CD34+ EnumerationD.R. Sutherland, L. Anderson, M. Keeney, R. Nayar, and I. Chin-YeeD.R. SutherlandSearch for more papers by this author, L. AndersonSearch for more papers by this author, M. KeeneySearch for more papers by this author, R. NayarSearch for more papers by this author, and I. Chin-YeeSearch for more papers by this authorPublished Online:27 Mar 2009https://doi.org/10.1089/scd.1.1997.6.85AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byCirculating CD34+ hematopoietic stem/progenitor cells paralleled with level of viremia in patients chronically infected with hepatitis B virus20 February 2018 | Regenerative Medicine Research, Vol. 6Standardized Flow Cytometry Assays for Enumerating CD34 + Hematopoietic Stem Cells27 January 2016Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis2 September 2015 | Hematology, Vol. 21, No. 1More than Just Quality ControlClinics in Laboratory Medicine, Vol. 27, No. 3Enumeration of CD 34 + Hematopoietic Stem and Progenitor Cells15 August 2003 | Current Protocols in Cytometry, Vol. 25, No. 1Validation of the single-platform ISHAGE method for CD34+ hematopoietic stem and progenitor cell enumeration in an international multicenter studyCytotherapy, Vol. 5, No. 1Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cellsSeminars in Hematology, Vol. 38, No. 2Single- versus dual-platform assays for human CD34+ cell enumerationCytometry, Vol. 38, No. 6Comparison of volumetric capillary cytometry with standard flow cytometry for routine enumeration of CD34+ cellsTransfusion, Vol. 39, No. 8The Absolute Number of Circulating CD34+ Cells as the Best Predictor of Peripheral Hematopoietic Stem Cell Yield Rita Fontao-Wendel, Arlete Lazar, Silvia Melges, Cristina Altobeli, and Silvano Wendel9 July 2004 | Journal of Hematotherapy, Vol. 8, No. 3Primordial role of CD34 + 38 − cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation4 January 2002 | British Journal of Haematology, Vol. 103, No. 2Role of the CD34+38− cells in posttransplant hematopoietic recovery4 June 2009 | STEM CELLS, Vol. 16, No. S2Quality assessment of CD34 + stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation25 December 2001 | British Journal of Haematology, Vol. 102, No. 2Tumor Evaluation and Hematotherapy: What Is the Situation in 1998?27 March 2009 | Journal of Hematotherapy, Vol. 7, No. 2A Convergence of Methods for a Worldwide Standard for CD34+ Cell Enumeration Genald Marti, Hans Johnsen, and Stefan Serke27 March 2009 | Journal of Hematotherapy, Vol. 7, No. 2Not All Healthy Donors Mobilize Hematopoietic Progenitor Cells Sufficiently After G-CSF Administration to Allow for Subsequent CD34 Purification of the Leukapheresis Product Mette Holm and Peter Hokland27 March 2009 | Journal of Hematotherapy, Vol. 7, No. 2Letter to the Editor: Will CD34+ Standardization Solve All Problems Related to Cell Therapy?27 March 2009 | Journal of Hematotherapy, Vol. 6, No. 5Current status of CD34+ cell analysis by flow cytometry: The ISHAGE guidelinesClinical Immunology Newsletter, Vol. 17, No. 2-3Quality Control in Flow Cytometry Volume 6Issue 2Apr 1997 To cite this article:D.R. Sutherland, L. Anderson, M. Keeney, R. Nayar, and I. Chin-Yee.Re: Toward a Worldwide Standard for CD34+ Enumeration.Journal of Hematotherapy.Apr 1997.85-89.http://doi.org/10.1089/scd.1.1997.6.85Published in Volume: 6 Issue 2: March 27, 2009PDF download

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.